Management of Pneumococcal Vaccine Reactions
Initial Assessment and Triage
- Most pneumococcal vaccine reactions are mild, self-limited local reactions requiring only reassurance and symptomatic management with analgesics or cold compresses, resolving within 48 hours without intervention 1, 2, 3, 4, 5
- Pain, erythema, and swelling at injection site occur in approximately 28-50% of recipients 5
- These reactions typically persist for less than 48 hours 1, 2, 3, 4
- Management: Reassurance, over-the-counter analgesics, and cold compresses are sufficient 5
Severe Reactions Requiring Immediate Intervention
- Severe systemic adverse effects including anaphylactic reactions are rare but require immediate emergency management 1, 2, 3, 4, 5
- Meta-analysis of nine randomized controlled trials found no reports of severe anaphylactic reactions among 7,531 patients 1, 2, 3, 4
- Management protocol: Administer intramuscular epinephrine immediately 7, activate emergency medical services 1, provide supportive care with IV fluids and airway management as needed 2
Critical Contraindications for Future Vaccination
- Revaccination is absolutely contraindicated in persons who experienced severe reactions (anaphylaxis or localized Arthus-type reactions) to the initial dose 8, 7, 6, 9, 10
- This is a firm guideline from the Advisory Committee on Immunization Practices and must be documented clearly in the patient's record 8, 7, 6, 9, 10
Reporting Requirements
- All suspected adverse events must be reported to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 1, 2, 3, 4, 5
Important Clinical Pearls
- Intradermal administration causes severe local reactions and is inappropriate—always use intramuscular route 1, 2, 3, 4
- No neurologic disorders (including Guillain-Barré syndrome) have been associated with pneumococcal vaccination 1, 2, 3, 4, 5
- Pneumococcal vaccination has not been causally associated with death among vaccine recipients 1, 2, 3, 4, 5
- Arthus-type reactions are more severe when revaccination occurs within 2 years, but reactions after intervals ≥4 years are not increased compared to initial vaccination 8, 7, 6, 9, 10